amobarbital has been researched along with Experimental Hepatoma in 3 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lebedev, OE | 1 |
| Sergeenko, NG | 1 |
| Barskiĭ, IIa | 1 |
| Papaian, GV | 1 |
| Diwan, BA | 2 |
| Rice, JM | 2 |
| Ward, JM | 2 |
| Ohshima, M | 2 |
| Lynch, PH | 1 |
| Dove, LF | 1 |
3 other studies available for amobarbital and Experimental Hepatoma
| Article | Year |
|---|---|
[Inhibitory analysis of the functions of the oxidative metabolic systems of tumor cells in tissue culture].
Topics: 2,4-Dinitrophenol; Amobarbital; Animals; Cell Line; Culture Techniques; Dinitrophenols; Flow Cytomet | 1984 |
Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 mice.
Topics: Adenocarcinoma; Adenoma; Amobarbital; Animals; Body Weight; Diethylnitrosamine; Liver Neoplasms, Exp | 1984 |
Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium, and barbituric acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine.
Topics: Amobarbital; Animals; Barbital; Barbiturates; Body Weight; Diethylnitrosamine; Liver Neoplasms, Expe | 1985 |